Kalydeco Approved in Europe to Treat Children with R117H Mutation
The European Commission has approved Kalydeco (ivacaftor) to treat children and adolescents with CF who carry the R117H mutation in the CFTR gene.
0 Comments
Kalydeco Approved in Europe to Treat Children with R117H Mutation
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed